Mark your calendars for this upcoming symposium on August 29th, which is a fundraising symposium to support Sickle Forward.
We’re thrilled to finally share our upcoming symposium, "Connecting the Dots: Bringing Cell and Gene Therapies to Patients," on August 29th. This event is a fundraising symposium to support Sickle Forward. Our goal from the get-go was ambitious: to gather world-class academics, venture capitalists, regulatory experts, and industry leaders to share their experiences in advancing cell and gene therapies from the lab to patients. The lineup so far is incredible: Unlocking the Potential of Your Project Kole Roybal- Associate Professor at University of California, San Francisco Director of the Parker Institute for Cancer Immunotherapy, and co-founder of Arsenal Biosciences, Inc. Daniel Bryan Goodman- Post-Doc in the Bluestone, Roybal, and Marson lab. Scientific Advisor to Manifold Bio, Retro Biosciences, and Arsenal Biosciences, Inc. Lexi Rovner- Co-Founder of 64x Bio Funding the Future of CGTs 5AM Ventures- Michelle Ho Curie.Bio- Jonathan Sockolosky Safely Bringing Therapies to Patients CDRH representative CDER/CBER representative CDO/reg representative Navigating the Ship Martin Borch Jensen- co-founder, CSO, Gordian Biotechnology Krishnan Viswanadhan, Pharm.D- President/COO, BeBio Sharon Benzeno- CCO, Adaptive Bio Andrew Allen- Co-Founder/CEO, Gritstone bio We are dedicated to creating a blend of academic and industry perspectives. Due to limited space, we’re offering free tickets to students through an application process, as well as reduced-price “Industry Early Backer” tickets. 🔗 Student ticket application: https://lnkd.in/gHbQvpej 🔗 Early industry tickets: https://lnkd.in/gPTkcsHr A special shoutout and THANK YOU to 5AM Ventures for being our first sponsor. We are seeking additional corporate sponsors to help make this event successful. Feel free to DM with any questions. Please join us for an amazing afternoon dedicated to learning and sharing together. #entrepreneurship #VC #bayarea #CellAndGeneTherapy #Biotech #SickleForward #Symposium #CGT #Innovation #Healthcare Current industry supporters of the Luke Timmerman Traverse supporting Sickle Forward include HemoTypeSC, Agios Pharmaceuticals, Vertex Pharmaceuticals, bluebird bio, Pfizer, CRISPR Therapeutics, Evercore, Beam Therapeutics, Fulcrum Therapeutics, Browne Consulting, and Rocket Pharmaceuticals